Skip to main content
. 2018 Mar 16;9:189. doi: 10.3389/fphar.2018.00189

Table 2.

Variations of laboratory parameters before and after isoquercetin in patients on sunitinib –*; ° Wilcoxon test for paired samples.

Laboratory test—Unit of measure Visit 1 Mean ± Standard deviation Visit 4 Mean ± Standard deviation P-value T-test for paired sample
Hemoglobin (g/dl) 13.8 ± 1.7 13.7 ± 2 0.876
Neutrophils (per mm3) 2.8 ± 1 2.5 ± 0.5 0.457
Lymphocytes (per mm3) 1.7 ± 0.4 1.7 ± 0.6 0.898
Platelet (per mm3) 233.1 ± 83.1 241.2 ± 79.2 0.750
FT3 pg/ml 2.7 ± 0.6 2.8 ± 0.5 0.807
Creatinin (mg/dL) 1.3 ± 0.2 1.4 ± 0.4 0.526
Total bilirubin (mg/dl) 0.7 ± 0.4 0.6 ± 0.3 0.712
SODIUM (mEq/L) 139.5 ± 4.1 139.6 ± 4 0.913
POTASSIUM (mEq/L) 4.6 ± 0.4 4.4 ± 0.4 0.142
CHLORIDE (mEq/L) 102.7 ± 1.6 103.2 ± 3.5 0.749
Visit 1 Median (25th; 75th percentile) Visit 4 Median (25th; 75th percentile) P-value Wilcoxon test for paired samples
GGT (IU/L) 33 (19; 50.8) 26 (18; 54) 0.172
TSH (mIU/L) 3.9 (1.3; 12.6) 4 (1.5; 12.4) 0.859
Glycemia (mg/dL) 97.5 (86.8; 117.3) 85 (76; 104.5) 0.093
AST (IU/L) 23.5 (20.5; 41) 27 (22; 34) 0.444
ALT (IU/L) 27.5 (15.3; 34.3) 23 (18; 38) 0.964